Sign in

    Matthew J. Hawkins

    Chief Executive Officer at Waystar Holding
    Board
    Since October 2017
    Age
    53 years
    Tenure
    Joined WAY in October 2017 as CEO and board member, leveraging extensive leadership experience from previous roles in healthcare technology and software solutions.

    Also at Waystar Holding

    CLS
    Christopher L. Schremser
    Chief Technology Officer (CTO)
    EL(SI
    Eric L. (Ric) Sinclair III
    Chief Business Officer
    GP
    Greg Packer
    Chief Legal Officer and Secretary

    About

    Matthew J. Hawkins, currently aged 53 as of February 12, 2025 , has been serving as the Chief Executive Officer and a member of the board of directors at WAY since October 2017. His appointment to this role reflects a deep background in leadership and operational management in the healthcare technology sector.

    Prior to joining WAY, he held significant positions at organizations such as Sunquest Information Systems, where he served as President from May 2014 to October 2017, as well as leadership roles with Vista Equity Partners and Henry Schein Practice Solutions.

    During his career, Hawkins has demonstrated a commitment to driving operational excellence and strategic innovation, skills that have been central to his roles in the industry. His broad experience across multiple high-level positions underscores his capability to lead and manage complex organizational structures.

    $WAY Performance Under Matthew J. Hawkins

    Past Roles

    OrganizationRoleDate RangeDetails
    Sunquest Information SystemsPresidentMay 2014 to October 2017Developer of medical laboratory and diagnostic software
    Greenway HealthPresident and board memberN/AHealth information technology vendor
    Vitera Healthcare SolutionsCEO and board memberN/AProvider of EHR, PM systems, and financial and clinical transaction processing
    SirsiDynixCEO and board memberN/ALibrary software automation company
    Henry Schein Practice SolutionsVice President and General Manager2004 to 2007Global healthcare distribution company

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Salary$800,000AnnualBase salary per employment agreement; subject to annual review
    Option Awards$17,349,946Grant DateAggregate grant-date fair value of time-based vesting stock options
    Stock Awards$10,750,000Grant DateAggregate grant-date fair value of time-based vesting RSUs
    All Other Compensation$50,480AnnualIncludes employer 401(k) matching ($6,900) and tax gross-up for executive gifts ($43,579)

    Performance Compensation

    Data from  FY 2024

    Performance Compensation Components

    MetricDetails
    ComponentNon-Equity Incentive Plan Compensation
    Target Incentive Opportunity$880,000 (110% of base salary $800,000)
    Actual Payout$994,437 (113% of the target incentive opportunity)
    Required Performance Metrics70% based on company financial performance (Adjusted EBITDA, Total gross bookings, Revenue); 25% based on leadership-shared metrics; 5% based on individual reflection of company values
    Vesting ScheduleNot subject to vesting; awarded as a cash bonus upon meeting performance targets
    Evaluation PeriodFY 2024
    Additional ConditionsPayout contingent on achieving predetermined performance metrics approved by the board at the beginning of the fiscal year